Randomized, Placebo-Controlled, Esophageal Squamous Cell Cancer Chemoprevention Trial of Selenomethionine and Celecoxib
- 30 September 2005
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 129 (3), 863-873
- https://doi.org/10.1053/j.gastro.2005.06.024
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk populationGut, 2005
- Failing the Public Health — Rofecoxib, Merck, and the FDANew England Journal of Medicine, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Trends in survival for both histologic types of esophageal cancer in U.S. surveillance, epidemiology and end results areasInternational Journal of Cancer, 2003
- Microsatellite alterations in esophageal dysplasia and squamous cell carcinoma from laser capture microdissected endoscopic biopsiesCancer Letters, 2003
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in NeoplasiaCritical Reviews in Clinical Laboratory Sciences, 2000
- Nutrition Intervention Trials in Linxian, China: Multiple Vitamin/Mineral Supplementation, Cancer Incidence, and Disease-Specific Mortality Among Adults With Esophageal DysplasiaJNCI Journal of the National Cancer Institute, 1993
- Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General PopulationJNCI Journal of the National Cancer Institute, 1993